• About Us
  • Home
Sunday, August 7, 2022
No Result
View All Result
NEWSLETTER
WiredNewsEngine
  • Home
  • Press Release
  • Entertainment
  • Health
  • Legal
  • Business
  • Featured
  • Current
  • Home
  • Press Release
  • Entertainment
  • Health
  • Legal
  • Business
  • Featured
  • Current
No Result
View All Result
WiredNewsEngine
No Result
View All Result
Home Business

InVitria Sponsors ESACT 2009 in Dublin Ireland

by WebMaster
June 6, 2009
in Business, Press Release
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

InVitria Sponsors ESACT 2009 in Dublin Ireland

InVitria, a leading supplier of performance enhancing cell culture media supplements, to sponsor the 21st Meeting of the European Society for Animal Cell Technology (ESACT) in Dublin, Ireland from June 7-10, 2009.

Fort Collins, CO June 5, 2009 /PRAvenueNW/ — The world-renowned ESACT ’09 gathering will serve as host to scientific experts from academia and industry brought together to find “Cellular Solutions for Clinical Challenges.” As one of the sponsors, InVitria will be sharing with attendees the powerful effects of its portfolio of cell culture media supplements developed to solve the regulatory and performance challenges facing the life science industry.

InVitria recently introduced a new product called ZAP-CHO, a performance enhancing cell culture media supplement designed to improve cell growth and antibody production in mammalian cell culture.

“ZAP-CHO improves CHO product development in chemically defined media that are completely free of animal components,” said Steve Pettit, Ph.D., Director of Cell Culture Development with InVitria. “Previously, the performance enhancements gained with ZAP-CHO was only possible by utilizing animal components such as FBS (fetal bovine serum or fetal calf serum) in cell culture media,” said Dr. Pettit.

Additionally, ZAP-CHO speeds-up cell line development and seed train expansion and also offers cost saving benefits by reducing operating costs as well as capital investment.

Recent publications, along with customer results has validated that another of InVitria’s leading cell culture supplements, Cellastim , a recombinant human serum albumin, outperforms other forms of albumin for growth and productivity. Cellastim is a key component in stem cell media and is used to safely optimize performance in CHO and hybridoma cell lines.

“ESACT is a tremendous venue to build awareness of InVitria’s product portfolio and collaborate with leaders in cellular biology,” said Scott Deeter, InVitria President and CEO. “InVitria’s products provide a unique opportunity for the cellular products industry to advance to a higher level of safety and productivity.”

Link to the news release:
http://www.b3cnewswire.com/popup.php?id=156

About InVitria – www.InVitria.com
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture products and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

Contact
Erik H. Vogel
InVitria
Marketing Manager
Phone: 1-800-916-8311
[email protected]
www.InVitria.com

WebMaster

WebMaster

Next Post

Florida Escambia Bay Bridge I-10 fatality

Popular News

  • Silencil Reviews – Does It Silence Tinnitus for Real?

    0 shares
    Share 0 Tweet 0
  • Clinitron Bed Management For Flap Patients Is The Standard Of Care

    0 shares
    Share 0 Tweet 0
  • Ceremony CBD Oil Reviews: Trustworthy Hemp CBD Liquid Drops?

    0 shares
    Share 0 Tweet 0
  • Kansas sperm donor asked to pay child support

    0 shares
    Share 0 Tweet 0
  • Organic Green CBD Review: Is OrganicGreen Hemp CBD Oil Safe?

    0 shares
    Share 0 Tweet 0

Rehabs Near Me Launches New Rehab Services in the US

February 25, 2021

Ginger-Powered Recoup Beverage: A Founder’s Unlikely Story of Survival and Success

February 13, 2021

What is Unix: The Base of All Operating Systems?

February 2, 2021

Categories

  • Banking
  • Bollywood
  • Brand Partner Content
  • Business
  • Cancer
  • Current
  • Entertainment
  • Featured
  • Finance
  • Health
  • Hollywood
  • Legal
  • Press Release
  • Technology
  • World News
  • Home
  • Press Release
  • Entertainment
  • Health
  • Legal
  • Business
  • Featured
  • Current

No Result
View All Result
  • About Us
  • Home